p21, p27, cyclin D1, and p53 in rectal cancer: Immunohistology with prognostic significance?

International Journal of Colorectal Disease

Volumn 17, Issue 1, 2002, Pages 11-19

  Schwandner, O ^a   Bruch, H P ^a   Broll, R ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Cell cycle; Prognosis; Rectal cancer; Recurrence; Survival

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PROTEIN P53; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; ENZYME INHIBITOR; PROTEIN P21; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECTUM CARCINOMA; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; DRUG ANTAGONISM; METABOLISM; MORTALITY; RECTUM TUMOR;

AGED; CELL CYCLE PROTEINS; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; ENZYME INHIBITORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROGNOSIS; PROTO-ONCOGENE PROTEINS P21(RAS); RECTAL NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0036355044     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003840100333     Document Type: Article

References (35)

1. Sherr CJ (1996) Cancer cell cycles. Science 274:1672-1677
2. Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163
3. Steeg PS, Abrams JS (1997) Cancer prognostics: past, present and p27. Nat Med 3:152-154
4. Hall M, Bates S, Peters G (1995) Evidence for different modes of action of cyclin-dependent kinase inhibitors: p 15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:211-219
5. Harper JW, Adami GR, Wie N, Keyomarsi K, Elledge SJ (1993) The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816
6. Xiong Y, Hannon GJ, Zang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704
7. Michieli R Chedid M, Lin D, Pierce JH, Mercer WD, Givol D (1994) Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395
8. Sgambato A, Cittadini A, Faraglia B, Weinstein IB (2000) Multiple functions of p27 (Kip1) and its alterations in tumor cells: a review. J Cell Physiol 183:18-27
9. Bates S, Peters G (1995) Cyclin D1 as a cellular proto-oncogene. Semin Cancer Biol 6:73-82
10. Bruch HP, Schwandner O (1998) Chirurgische Therapie des Rektumkarzinoms: Standard und TME. In: Buechler MW, Heald RJ, Ulrich B (eds) Rektumkarzinom: das Konzept der Totalen Mesorektalen Exzision. Basel, Karger, pp 104-111
11. Bruch HP, Schwandner O, Schiedeck THK, Roblick UJ (1999) Actual Standards and controversies on operative technique and lymph-node dissection in colorectal cancer. Langenbeck Arch Surg 384:167-175
12. Wexner SD, Rotholtz NA (2000) Surgeon influenced variables in resectional rectal cancer surgery. Dis Colon Rectum 43:1606-1627
13. Heald RJ, Smedh RK, Kald A, Sexton R, Moran BJ (1997) Abdominoperineal excision of the rectum - an endangered operation. Dis Colon Rectum 40:747-751
14. Bokey EL, Chapuis PH, Dent OF, et al (1997) Factors affecting survival after excision of the rectum for cancer: a multivariate analysis. Dis Colon Rectum 40:3-10
15. Freedman LS, Mcaskill P, Smith AN (1984) Multivariate analysis of prognostic factors for operable rectal cancer. Lancet 29:733-736
16. Obrand DI, Gordon PH (1997) Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 40:15-24
17. Park YJ, Youk LG, Choi HS, Han SU, Park KJ, Lee KU, Choe KJ, Park JG (1999) Experience of 1446 rectal cancer patients in Korea and analysis of prognostic factors. Int J Colorectal Dis 14:101-106
18. Schwandner O, Schiedeck THK, Killaitis C, Bruch HP (1999) A case-control-study comparing laparoscopic versus open surgery for rectosigmoidal and rectal cancer. Int J Colorectal Dis 14:158-163
19. Galandiuk S, Wieand HS, Moertel CG, et al (1992) Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 174:27-32
20. Michelassi F, Vannucci L, Ayala JJ, Chappel R, Goldberg R, Block GE (1990) Local recurrence after curative resection of colorectal adenocarcinoma. Surgery 108:787-792
21. Konn M, Morita T, Hada R, et al (1993) Survival and recurrence after low anterior resection and abdominoperineal resection for rectal cancer: the results of a long-term study with a review of the literature. Surg Today 23:21-30
22. Fu CG, Tominaga O, Nagawa H, Nita ME, Masaki T, Ishimaru G, Higuchi Y, Tsuruo T, Muto T (1998) Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients. Dis Colon Rectum 41:68-74
23. Galindo Gallego M, Fernandez Acenero MJ, Sanz Ortega J, Aljama Delgado A, Balibera Cantero JL (2000) Prognostic influence of p53 nuclear overexpression in colorectal carcinoma. Dis Colon Rectum 43:971-975
24. Qiu H, Sirivongs P, Rothenberger M, Rothenberger DA, Garcia-Aguilar J (2000) Molecular prognostic factors in rectal cancer treated by radiation and surgery. Dis Colon Rectum 43:451-459
25. Zirbes TK, Baldus SE, Moenig SP, Nolden S, Kunze D, Shafizadeh ST, Schneider PM, Thiele J, Hoelscher AH, Dienes HP (2000) Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer 89:14-18
26. Bukholm IK, Nesland JM (2000) Protein expression of p53, p21 (WAF1/CIP1), bcl-2, Bax, cyclin D1 and pRb in human colon carcinomas. Virchows Arch 436:224-228
27. Girlando S, Slomp R Caffo O, Amichetti M, Togni R, Dvornik G, Tomio L, Calligioni E, D'alla Palma P, Barbareschi M (1999) p21 expression in colorectal carcinomas: a study on 103 cases with analysis of p53 gene mutation/expression and clinic-pathological correlations. Virchows Arch 435:559-565
28. Palmquist R, Stenling R, Oberg A, Landberg G (1999) Prognostic significance of p27 (Kip1) expression in colorectal cancer: a clinico-pathological characterization. J Pathol 188:18-23
29. kip1 protein expression: an independent prognostic factor in rectal carcinoma stages I-III. Colorectal Dis 1:315-323
30. Tenjo T, Toyoda M, Okuda J, Watanabe I, Yamamoto T, Tanaka K, Ohtani M, Nohara T, Kawasaki H, Tanigawa N (2000) Prognostic significance of p27 (kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas. Oncology 58:45-51
31. McKay JA, Douglas JJ, Ross VG, Curran S, Ahmed FY, Loane JF, Murray GI, McLeod HL (2000) Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases. Clin Cancer Res 6:1113-1118
32. Schwandner O, Schiedeck THK, Bruch HP, Duchrow M, Windhoevel U, Broll R (2000) Apoptosis in rectal cancer: prognostic significance in comparison with clinical, histopathologic, and immunohistochemical variables. Dis Colon Rectum 43:1227-1236
33. Schwandner O, Schiedeck THK, Bruch HP, Duchrow M, Windhoevel U, Broll R (2000) p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer. Eur J Cancer 36:348-356
34. Finlay CA, Hinds PW, Tan TH, Eliyahu D, Oren M, Levine AJ (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc 700-p53 complex with an altered half-life. Mol Cell Biol 8:531-539
35. Brugarolas J, Chandrasekaran C, Gordor JI, Beach D, Jacks T, Hannon GJ (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377:552-557